Global Biodefense Market Growth (Status and Outlook) 2022-2028
As the global economy mends, the 2021 growth of Biodefense will have significant change from previous year. According to our latest study, the global Biodefense market size is USD million in 2022 from USD 1119.1 million in 2021, with a change of % between 2021 and 2022. The global Biodefense market size will reach USD 1865.5 million in 2028, growing at a CAGR of 7.6% over the analysis period.
The United States Biodefense market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Biodefense market, reaching US$ million by the year 2028. As for the Europe Biodefense landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Biodefense players cover Emergent Biosolutions, Hytest, GSK, and Sanofi, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Biodefense market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Anthrax
Smallpox
Botulism
Radiation/Nuclear
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
US Military Market
US Civilian Market
Non - US Market
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Emergent Biosolutions
Hytest
GSK
Sanofi
PharmAthene
Bavarian Nordic
SIGA Technologies
Arbutus Biopharma
DynPort Vaccine
Xoma Corporation
Ichor Medical Systems
Aeolus Pharmaceuticals
Achaogen
Elusys Therapeutics
Dynavax Technologies
Cleveland BioLabs
Soligenix
Alnylam Pharmaceuticals
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Biodefense Market Size 2017-2028
2.1.2 Biodefense Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Biodefense Segment by Type
2.2.1 Anthrax
2.2.2 Smallpox
2.2.3 Botulism
2.2.4 Radiation/Nuclear
2.2.5 Others
2.3 Biodefense Market Size by Type
2.3.1 Biodefense Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Biodefense Market Size Market Share by Type (2017-2022)
2.4 Biodefense Segment by Application
2.4.1 US Military Market
2.4.2 US Civilian Market
2.4.3 Non - US Market
2.5 Biodefense Market Size by Application
2.5.1 Biodefense Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Biodefense Market Size Market Share by Application (2017-2022)
3 Biodefense Market Size by Player
3.1 Biodefense Market Size Market Share by Players
3.1.1 Global Biodefense Revenue by Players (2020-2022)
3.1.2 Global Biodefense Revenue Market Share by Players (2020-2022)
3.2 Global Biodefense Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Biodefense by Regions
4.1 Biodefense Market Size by Regions (2017-2022)
4.2 Americas Biodefense Market Size Growth (2017-2022)
4.3 APAC Biodefense Market Size Growth (2017-2022)
4.4 Europe Biodefense Market Size Growth (2017-2022)
4.5 Middle East & Africa Biodefense Market Size Growth (2017-2022)
5 Americas
5.1 Americas Biodefense Market Size by Country (2017-2022)
5.2 Americas Biodefense Market Size by Type (2017-2022)
5.3 Americas Biodefense Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Biodefense Market Size by Region (2017-2022)
6.2 APAC Biodefense Market Size by Type (2017-2022)
6.3 APAC Biodefense Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Biodefense by Country (2017-2022)
7.2 Europe Biodefense Market Size by Type (2017-2022)
7.3 Europe Biodefense Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Biodefense by Region (2017-2022)
8.2 Middle East & Africa Biodefense Market Size by Type (2017-2022)
8.3 Middle East & Africa Biodefense Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Biodefense Market Forecast
10.1 Global Biodefense Forecast by Regions (2023-2028)
10.1.1 Global Biodefense Forecast by Regions (2023-2028)
10.1.2 Americas Biodefense Forecast
10.1.3 APAC Biodefense Forecast
10.1.4 Europe Biodefense Forecast
10.1.5 Middle East & Africa Biodefense Forecast
10.2 Americas Biodefense Forecast by Country (2023-2028)
10.2.1 United States Biodefense Market Forecast
10.2.2 Canada Biodefense Market Forecast
10.2.3 Mexico Biodefense Market Forecast
10.2.4 Brazil Biodefense Market Forecast
10.3 APAC Biodefense Forecast by Region (2023-2028)
10.3.1 China Biodefense Market Forecast
10.3.2 Japan Biodefense Market Forecast
10.3.3 Korea Biodefense Market Forecast
10.3.4 Southeast Asia Biodefense Market Forecast
10.3.5 India Biodefense Market Forecast
10.3.6 Australia Biodefense Market Forecast
10.4 Europe Biodefense Forecast by Country (2023-2028)
10.4.1 Germany Biodefense Market Forecast
10.4.2 France Biodefense Market Forecast
10.4.3 UK Biodefense Market Forecast
10.4.4 Italy Biodefense Market Forecast
10.4.5 Russia Biodefense Market Forecast
10.5 Middle East & Africa Biodefense Forecast by Region (2023-2028)
10.5.1 Egypt Biodefense Market Forecast
10.5.2 South Africa Biodefense Market Forecast
10.5.3 Israel Biodefense Market Forecast
10.5.4 Turkey Biodefense Market Forecast
10.5.5 GCC Countries Biodefense Market Forecast
10.6 Global Biodefense Forecast by Type (2023-2028)
10.7 Global Biodefense Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Emergent Biosolutions
11.1.1 Emergent Biosolutions Company Information
11.1.2 Emergent Biosolutions Biodefense Product Offered
11.1.3 Emergent Biosolutions Biodefense Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Emergent Biosolutions Main Business Overview
11.1.5 Emergent Biosolutions Latest Developments
11.2 Hytest
11.2.1 Hytest Company Information
11.2.2 Hytest Biodefense Product Offered
11.2.3 Hytest Biodefense Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Hytest Main Business Overview
11.2.5 Hytest Latest Developments
11.3 GSK
11.3.1 GSK Company Information
11.3.2 GSK Biodefense Product Offered
11.3.3 GSK Biodefense Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 GSK Main Business Overview
11.3.5 GSK Latest Developments
11.4 Sanofi
11.4.1 Sanofi Company Information
11.4.2 Sanofi Biodefense Product Offered
11.4.3 Sanofi Biodefense Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Sanofi Main Business Overview
11.4.5 Sanofi Latest Developments
11.5 PharmAthene
11.5.1 PharmAthene Company Information
11.5.2 PharmAthene Biodefense Product Offered
11.5.3 PharmAthene Biodefense Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 PharmAthene Main Business Overview
11.5.5 PharmAthene Latest Developments
11.6 Bavarian Nordic
11.6.1 Bavarian Nordic Company Information
11.6.2 Bavarian Nordic Biodefense Product Offered
11.6.3 Bavarian Nordic Biodefense Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Bavarian Nordic Main Business Overview
11.6.5 Bavarian Nordic Latest Developments
11.7 SIGA Technologies
11.7.1 SIGA Technologies Company Information
11.7.2 SIGA Technologies Biodefense Product Offered
11.7.3 SIGA Technologies Biodefense Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 SIGA Technologies Main Business Overview
11.7.5 SIGA Technologies Latest Developments
11.8 Arbutus Biopharma
11.8.1 Arbutus Biopharma Company Information
11.8.2 Arbutus Biopharma Biodefense Product Offered
11.8.3 Arbutus Biopharma Biodefense Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Arbutus Biopharma Main Business Overview
11.8.5 Arbutus Biopharma Latest Developments
11.9 DynPort Vaccine
11.9.1 DynPort Vaccine Company Information
11.9.2 DynPort Vaccine Biodefense Product Offered
11.9.3 DynPort Vaccine Biodefense Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 DynPort Vaccine Main Business Overview
11.9.5 DynPort Vaccine Latest Developments
11.10 Xoma Corporation
11.10.1 Xoma Corporation Company Information
11.10.2 Xoma Corporation Biodefense Product Offered
11.10.3 Xoma Corporation Biodefense Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Xoma Corporation Main Business Overview
11.10.5 Xoma Corporation Latest Developments
11. Ichor Medical Systems
11.11.1 Ichor Medical Systems Company Information
11.11.2 Ichor Medical Systems Biodefense Product Offered
11.11.3 Ichor Medical Systems Biodefense Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 Ichor Medical Systems Main Business Overview
11.11.5 Ichor Medical Systems Latest Developments
11.12 Aeolus Pharmaceuticals
11.12.1 Aeolus Pharmaceuticals Company Information
11.12.2 Aeolus Pharmaceuticals Biodefense Product Offered
11.12.3 Aeolus Pharmaceuticals Biodefense Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 Aeolus Pharmaceuticals Main Business Overview
11.12.5 Aeolus Pharmaceuticals Latest Developments
11.13 Achaogen
11.13.1 Achaogen Company Information
11.13.2 Achaogen Biodefense Product Offered
11.13.3 Achaogen Biodefense Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 Achaogen Main Business Overview
11.13.5 Achaogen Latest Developments
11.14 Elusys Therapeutics
11.14.1 Elusys Therapeutics Company Information
11.14.2 Elusys Therapeutics Biodefense Product Offered
11.14.3 Elusys Therapeutics Biodefense Revenue, Gross Margin and Market Share (2020-2022)
11.14.4 Elusys Therapeutics Main Business Overview
11.14.5 Elusys Therapeutics Latest Developments
11.15 Dynavax Technologies
11.15.1 Dynavax Technologies Company Information
11.15.2 Dynavax Technologies Biodefense Product Offered
11.15.3 Dynavax Technologies Biodefense Revenue, Gross Margin and Market Share (2020-2022)
11.15.4 Dynavax Technologies Main Business Overview
11.15.5 Dynavax Technologies Latest Developments
11.16 Cleveland BioLabs
11.16.1 Cleveland BioLabs Company Information
11.16.2 Cleveland BioLabs Biodefense Product Offered
11.16.3 Cleveland BioLabs Biodefense Revenue, Gross Margin and Market Share (2020-2022)
11.16.4 Cleveland BioLabs Main Business Overview
11.16.5 Cleveland BioLabs Latest Developments
11.17 Soligenix
11.17.1 Soligenix Company Information
11.17.2 Soligenix Biodefense Product Offered
11.17.3 Soligenix Biodefense Revenue, Gross Margin and Market Share (2020-2022)
11.17.4 Soligenix Main Business Overview
11.17.5 Soligenix Latest Developments
11.18 Alnylam Pharmaceuticals
11.18.1 Alnylam Pharmaceuticals Company Information
11.18.2 Alnylam Pharmaceuticals Biodefense Product Offered
11.18.3 Alnylam Pharmaceuticals Biodefense Revenue, Gross Margin and Market Share (2020-2022)
11.18.4 Alnylam Pharmaceuticals Main Business Overview
11.18.5 Alnylam Pharmaceuticals Latest Developments
12 Research Findings and Conclusion
List of Tables
Table 1. Biodefense Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Anthrax
Table 3. Major Players of Smallpox
Table 4. Major Players of Botulism
Table 5. Major Players of Radiation/Nuclear
Table 6. Major Players of Others
Table 7. Biodefense Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global Biodefense Market Size by Type (2017-2022) & ($ Millions)
Table 9. Global Biodefense Market Size Market Share by Type (2017-2022)
Table 10. Biodefense Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 11. Global Biodefense Market Size by Application (2017-2022) & ($ Millions)
Table 12. Global Biodefense Market Size Market Share by Application (2017-2022)
Table 13. Global Biodefense Revenue by Players (2020-2022) & ($ Millions)
Table 14. Global Biodefense Revenue Market Share by Player (2020-2022)
Table 15. Biodefense Key Players Head office and Products Offered
Table 16. Biodefense Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Biodefense Market Size by Regions 2017-2022 & ($ Millions)
Table 20. Global Biodefense Market Size Market Share by Regions (2017-2022)
Table 21. Americas Biodefense Market Size by Country (2017-2022) & ($ Millions)
Table 22. Americas Biodefense Market Size Market Share by Country (2017-2022)
Table 23. Americas Biodefense Market Size by Type (2017-2022) & ($ Millions)
Table 24. Americas Biodefense Market Size Market Share by Type (2017-2022)
Table 25. Americas Biodefense Market Size by Application (2017-2022) & ($ Millions)
Table 26. Americas Biodefense Market Size Market Share by Application (2017-2022)
Table 27. APAC Biodefense Market Size by Region (2017-2022) & ($ Millions)
Table 28. APAC Biodefense Market Size Market Share by Region (2017-2022)
Table 29. APAC Biodefense Market Size by Type (2017-2022) & ($ Millions)
Table 30. APAC Biodefense Market Size Market Share by Type (2017-2022)
Table 31. APAC Biodefense Market Size by Application (2017-2022) & ($ Millions)
Table 32. APAC Biodefense Market Size Market Share by Application (2017-2022)
Table 33. Europe Biodefense Market Size by Country (2017-2022) & ($ Millions)
Table 34. Europe Biodefense Market Size Market Share by Country (2017-2022)
Table 35. Europe Biodefense Market Size by Type (2017-2022) & ($ Millions)
Table 36. Europe Biodefense Market Size Market Share by Type (2017-2022)
Table 37. Europe Biodefense Market Size by Application (2017-2022) & ($ Millions)
Table 38. Europe Biodefense Market Size Market Share by Application (2017-2022)
Table 39. Middle East & Africa Biodefense Market Size by Region (2017-2022) & ($ Millions)
Table 40. Middle East & Africa Biodefense Market Size Market Share by Region (2017-2022)
Table 41. Middle East & Africa Biodefense Market Size by Type (2017-2022) & ($ Millions)
Table 42. Middle East & Africa Biodefense Market Size Market Share by Type (2017-2022)
Table 43. Middle East & Africa Biodefense Market Size by Application (2017-2022) & ($ Millions)
Table 44. Middle East & Africa Biodefense Market Size Market Share by Application (2017-2022)
Table 45. Key Market Drivers & Growth Opportunities of Biodefense
Table 46. Key Market Challenges & Risks of Biodefense
Table 47. Key Industry Trends of Biodefense
Table 48. Global Biodefense Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 49. Global Biodefense Market Size Market Share Forecast by Regions (2023-2028)
Table 50. Global Biodefense Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 51. Global Biodefense Market Size Market Share Forecast by Type (2023-2028)
Table 52. Global Biodefense Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 53. Global Biodefense Market Size Market Share Forecast by Application (2023-2028)
Table 54. Emergent Biosolutions Details, Company Type, Biodefense Area Served and Its Competitors
Table 55. Emergent Biosolutions Biodefense Product Offered
Table 56. Emergent Biosolutions Biodefense Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 57. Emergent Biosolutions Main Business
Table 58. Emergent Biosolutions Latest Developments
Table 59. Hytest Details, Company Type, Biodefense Area Served and Its Competitors
Table 60. Hytest Biodefense Product Offered
Table 61. Hytest Main Business
Table 62. Hytest Biodefense Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 63. Hytest Latest Developments
Table 64. GSK Details, Company Type, Biodefense Area Served and Its Competitors
Table 65. GSK Biodefense Product Offered
Table 66. GSK Main Business
Table 67. GSK Biodefense Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 68. GSK Latest Developments
Table 69. Sanofi Details, Company Type, Biodefense Area Served and Its Competitors
Table 70. Sanofi Biodefense Product Offered
Table 71. Sanofi Main Business
Table 72. Sanofi Biodefense Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 73. Sanofi Latest Developments
Table 74. PharmAthene Details, Company Type, Biodefense Area Served and Its Competitors
Table 75. PharmAthene Biodefense Product Offered
Table 76. PharmAthene Main Business
Table 77. PharmAthene Biodefense Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 78. PharmAthene Latest Developments
Table 79. Bavarian Nordic Details, Company Type, Biodefense Area Served and Its Competitors
Table 80. Bavarian Nordic Biodefense Product Offered
Table 81. Bavarian Nordic Main Business
Table 82. Bavarian Nordic Biodefense Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 83. Bavarian Nordic Latest Developments
Table 84. SIGA Technologies Details, Company Type, Biodefense Area Served and Its Competitors
Table 85. SIGA Technologies Biodefense Product Offered
Table 86. SIGA Technologies Main Business
Table 87. SIGA Technologies Biodefense Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 88. SIGA Technologies Latest Developments
Table 89. Arbutus Biopharma Details, Company Type, Biodefense Area Served and Its Competitors
Table 90. Arbutus Biopharma Biodefense Product Offered
Table 91. Arbutus Biopharma Main Business
Table 92. Arbutus Biopharma Biodefense Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 93. Arbutus Biopharma Latest Developments
Table 94. DynPort Vaccine Details, Company Type, Biodefense Area Served and Its Competitors
Table 95. DynPort Vaccine Biodefense Product Offered
Table 96. DynPort Vaccine Main Business
Table 97. DynPort Vaccine Biodefense Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 98. DynPort Vaccine Latest Developments
Table 99. Xoma Corporation Details, Company Type, Biodefense Area Served and Its Competitors
Table 100. Xoma Corporation Biodefense Product Offered
Table 101. Xoma Corporation Main Business
Table 102. Xoma Corporation Biodefense Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 103. Xoma Corporation Latest Developments
Table 104. Ichor Medical Systems Details, Company Type, Biodefense Area Served and Its Competitors
Table 105. Ichor Medical Systems Biodefense Product Offered
Table 106. Ichor Medical Systems Biodefense Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 107. Ichor Medical Systems Main Business
Table 108. Ichor Medical Systems Latest Developments
Table 109. Aeolus Pharmaceuticals Details, Company Type, Biodefense Area Served and Its Competitors
Table 110. Aeolus Pharmaceuticals Biodefense Product Offered
Table 111. Aeolus Pharmaceuticals Main Business
Table 112. Aeolus Pharmaceuticals Biodefense Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 113. Aeolus Pharmaceuticals Latest Developments
Table 114. Achaogen Details, Company Type, Biodefense Area Served and Its Competitors
Table 115. Achaogen Biodefense Product Offered
Table 116. Achaogen Main Business
Table 117. Achaogen Biodefense Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 118. Achaogen Latest Developments
Table 119. Elusys Therapeutics Details, Company Type, Biodefense Area Served and Its Competitors
Table 120. Elusys Therapeutics Biodefense Product Offered
Table 121. Elusys Therapeutics Main Business
Table 122. Elusys Therapeutics Biodefense Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 123. Elusys Therapeutics Latest Developments
Table 124. Dynavax Technologies Details, Company Type, Biodefense Area Served and Its Competitors
Table 125. Dynavax Technologies Biodefense Product Offered
Table 126. Dynavax Technologies Main Business
Table 127. Dynavax Technologies Biodefense Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 128. Dynavax Technologies Latest Developments
Table 129. Cleveland BioLabs Details, Company Type, Biodefense Area Served and Its Competitors
Table 130. Cleveland BioLabs Biodefense Product Offered
Table 131. Cleveland BioLabs Main Business
Table 132. Cleveland BioLabs Biodefense Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 133. Cleveland BioLabs Latest Developments
Table 134. Soligenix Details, Company Type, Biodefense Area Served and Its Competitors
Table 135. Soligenix Biodefense Product Offered
Table 136. Soligenix Main Business
Table 137. Soligenix Biodefense Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 138. Soligenix Latest Developments
Table 139. Alnylam Pharmaceuticals Details, Company Type, Biodefense Area Served and Its Competitors
Table 140. Alnylam Pharmaceuticals Biodefense Product Offered
Table 141. Alnylam Pharmaceuticals Main Business
Table 142. Alnylam Pharmaceuticals Biodefense Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 143. Alnylam Pharmaceuticals Latest Developments
List of Figures
Figure 1. Biodefense Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Biodefense Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Biodefense Market Size Market Share by Type in 2021
Figure 7. Biodefense in US Military Market
Figure 8. Global Biodefense Market: US Military Market (2017-2022) & ($ Millions)
Figure 9. Biodefense in US Civilian Market
Figure 10. Global Biodefense Market: US Civilian Market (2017-2022) & ($ Millions)
Figure 11. Biodefense in Non - US Market
Figure 12. Global Biodefense Market: Non - US Market (2017-2022) & ($ Millions)
Figure 13. Global Biodefense Market Size Market Share by Application in 2021
Figure 14. Global Biodefense Revenue Market Share by Player in 2021
Figure 15. Global Biodefense Market Size Market Share by Regions (2017-2022)
Figure 16. Americas Biodefense Market Size 2017-2022 ($ Millions)
Figure 17. APAC Biodefense Market Size 2017-2022 ($ Millions)
Figure 18. Europe Biodefense Market Size 2017-2022 ($ Millions)
Figure 19. Middle East & Africa Biodefense Market Size 2017-2022 ($ Millions)
Figure 20. Americas Biodefense Value Market Share by Country in 2021
Figure 21. Americas Biodefense Consumption Market Share by Type in 2021
Figure 22. Americas Biodefense Market Size Market Share by Application in 2021
Figure 23. United States Biodefense Market Size Growth 2017-2022 ($ Millions)
Figure 24. Canada Biodefense Market Size Growth 2017-2022 ($ Millions)
Figure 25. Mexico Biodefense Market Size Growth 2017-2022 ($ Millions)
Figure 26. Brazil Biodefense Market Size Growth 2017-2022 ($ Millions)
Figure 27. APAC Biodefense Market Size Market Share by Region in 2021
Figure 28. APAC Biodefense Market Size Market Share by Application in 2021
Figure 29. China Biodefense Market Size Growth 2017-2022 ($ Millions)
Figure 30. Japan Biodefense Market Size Growth 2017-2022 ($ Millions)
Figure 31. Korea Biodefense Market Size Growth 2017-2022 ($ Millions)
Figure 32. Southeast Asia Biodefense Market Size Growth 2017-2022 ($ Millions)
Figure 33. India Biodefense Market Size Growth 2017-2022 ($ Millions)
Figure 34. Australia Biodefense Market Size Growth 2017-2022 ($ Millions)
Figure 35. Europe Biodefense Market Size Market Share by Country in 2021
Figure 36. Europe Biodefense Market Size Market Share by Type in 2021
Figure 37. Europe Biodefense Market Size Market Share by Application in 2021
Figure 38. Germany Biodefense Market Size Growth 2017-2022 ($ Millions)
Figure 39. France Biodefense Market Size Growth 2017-2022 ($ Millions)
Figure 40. UK Biodefense Market Size Growth 2017-2022 ($ Millions)
Figure 41. Italy Biodefense Market Size Growth 2017-2022 ($ Millions)
Figure 42. Russia Biodefense Market Size Growth 2017-2022 ($ Millions)
Figure 43. Middle East & Africa Biodefense Market Size Market Share by Region in 2021
Figure 44. Middle East & Africa Biodefense Market Size Market Share by Type in 2021
Figure 45. Middle East & Africa Biodefense Market Size Market Share by Application in 2021
Figure 46. Egypt Biodefense Market Size Growth 2017-2022 ($ Millions)
Figure 47. South Africa Biodefense Market Size Growth 2017-2022 ($ Millions)
Figure 48. Israel Biodefense Market Size Growth 2017-2022 ($ Millions)
Figure 49. Turkey Biodefense Market Size Growth 2017-2022 ($ Millions)
Figure 50. GCC Country Biodefense Market Size Growth 2017-2022 ($ Millions)
Figure 51. Americas Biodefense Market Size 2023-2028 ($ Millions)
Figure 52. APAC Biodefense Market Size 2023-2028 ($ Millions)
Figure 53. Europe Biodefense Market Size 2023-2028 ($ Millions)
Figure 54. Middle East & Africa Biodefense Market Size 2023-2028 ($ Millions)
Figure 55. United States Biodefense Market Size 2023-2028 ($ Millions)
Figure 56. Canada Biodefense Market Size 2023-2028 ($ Millions)
Figure 57. Mexico Biodefense Market Size 2023-2028 ($ Millions)
Figure 58. Brazil Biodefense Market Size 2023-2028 ($ Millions)
Figure 59. China Biodefense Market Size 2023-2028 ($ Millions)
Figure 60. Japan Biodefense Market Size 2023-2028 ($ Millions)
Figure 61. Korea Biodefense Market Size 2023-2028 ($ Millions)
Figure 62. Southeast Asia Biodefense Market Size 2023-2028 ($ Millions)
Figure 63. India Biodefense Market Size 2023-2028 ($ Millions)
Figure 64. Australia Biodefense Market Size 2023-2028 ($ Millions)
Figure 65. Germany Biodefense Market Size 2023-2028 ($ Millions)
Figure 66. France Biodefense Market Size 2023-2028 ($ Millions)
Figure 67. UK Biodefense Market Size 2023-2028 ($ Millions)
Figure 68. Italy Biodefense Market Size 2023-2028 ($ Millions)
Figure 69. Russia Biodefense Market Size 2023-2028 ($ Millions)
Figure 70. Spain Biodefense Market Size 2023-2028 ($ Millions)
Figure 71. Egypt Biodefense Market Size 2023-2028 ($ Millions)
Figure 72. South Africa Biodefense Market Size 2023-2028 ($ Millions)
Figure 73. Israel Biodefense Market Size 2023-2028 ($ Millions)
Figure 74. Turkey Biodefense Market Size 2023-2028 ($ Millions)
Figure 75. GCC Countries Biodefense Market Size 2023-2028 ($ Millions)
